17:07 IST
BSE
Board Meeting Date
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd will hold a board meeting on August 12, 2026. The board will consider and approve financial results for the quarter ended June 30, 2026.
Bliss GVS Pharma Ltd
- Share price
- ₹685.00
- Market cap
- ₹7,284 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 53.5×Sector 47.4×
- Promoter holding
- 35.01%-0.35% QoQ
- FII holding
- 8.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Open Offer 7Employee Stock Options 7Annual General Meeting 6Management Change 4Other Announcement 3Financial Results 3Board Meeting Date 3Promoter Selling 2Capital Structure Change 2Credit Rating 1Business Update 1Acquisition 1
Time
3 announcements with these filters
18:20 IST
NSE
Board Meeting Date
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Limited has scheduled a board meeting for May 12, 2026, to consider audited financial results for the year ended March 2026 and recommend a final dividend. The trading window for designated persons is closed from April 1, 2026, until May 14, 2026.
18:19 IST
BSE
Board Meeting Date
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd has scheduled a board meeting on May 12, 2026, to approve audited standalone and consolidated financial results for FY2026. The board will also consider recommending a final dividend. The trading window for designated persons remains closed until 48 hours after the results announcement.